‘Kyprolis’ receives health insurance benefits with RSA from 5 February
‘Kyprolis Inj,’ an Amgen’s multiple myeloma therapy, has passed the Health Insurance Policy Deliberation Committee
Along with enforcement of the life-prolonging treatment, the government will also carry out other plans, such as a demo project for health insurance benefits and revise of health in...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.